These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Nonalcoholic fatty liver disease: pharmacologic and surgical options. Parikh N; Ahmad J Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273 [TBL] [Abstract][Full Text] [Related]
86. [Nonalcoholic steatohepatitis: a review]. Jacquemin G Rev Med Liege; 2003 Mar; 58(3):147-54. PubMed ID: 12723508 [TBL] [Abstract][Full Text] [Related]
87. Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. Pardee PE; Lavine JE; Schwimmer JB Semin Pediatr Surg; 2009 Aug; 18(3):144-51. PubMed ID: 19573756 [TBL] [Abstract][Full Text] [Related]
88. [NASH now accepted as a diagnosis]. Pikkarainen P Duodecim; 2003; 119(6):486-91. PubMed ID: 12708335 [No Abstract] [Full Text] [Related]
89. [Treatment and prevention effects of weight loss on obese patients with nonalcoholic fatty liver disease]. Shi YF; Zhu HJ Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):112. PubMed ID: 12648412 [No Abstract] [Full Text] [Related]
90. Nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and bariatric surgery: a review. Helling TS; Gurram K Surg Obes Relat Dis; 2006; 2(2):213-20. PubMed ID: 16925347 [No Abstract] [Full Text] [Related]
91. Nonalcoholic fatty liver disease and bariatric surgery in adolescents. Holterman A; Gurria J; Tanpure S; DiSomma N Semin Pediatr Surg; 2014 Feb; 23(1):49-57. PubMed ID: 24491369 [TBL] [Abstract][Full Text] [Related]
92. Steatohepatitis and unsuspected micronodular cirrhosis in Dorfman-Chanarin syndrome with documented ABHD5 mutation. Srinivasan R; Hadzić N; Fischer J; Knisely AS J Pediatr; 2004 May; 144(5):662-5. PubMed ID: 15127008 [TBL] [Abstract][Full Text] [Related]
93. Fatty liver--current look at the old disease. Mach T Med Sci Monit; 2000; 6(1):209-16. PubMed ID: 11208312 [TBL] [Abstract][Full Text] [Related]
94. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. James OF; Day CP J Hepatol; 1998 Sep; 29(3):495-501. PubMed ID: 9765002 [No Abstract] [Full Text] [Related]
95. Non-alcoholic steatohepatitis: an overview. Shifflet A; Wu GY J Formos Med Assoc; 2009 Jan; 108(1):4-12. PubMed ID: 19181602 [TBL] [Abstract][Full Text] [Related]
96. Nonalcoholic steatohepatitis in children. Roberts EA Curr Gastroenterol Rep; 2003 Jun; 5(3):253-9. PubMed ID: 12734049 [TBL] [Abstract][Full Text] [Related]
97. Nonalcoholic fatty liver disease. Jonas MM Adolesc Med Clin; 2004 Feb; 15(1):159-73, xi. PubMed ID: 15272263 [TBL] [Abstract][Full Text] [Related]
98. Nonalcoholic fatty liver disease: an agenda for clinical research. Younossi ZM; Diehl AM; Ong JP Hepatology; 2002 Apr; 35(4):746-52. PubMed ID: 11915019 [No Abstract] [Full Text] [Related]